AVIR logo

Atea Pharmaceuticals (AVIR) Cash From Operations

Annual CFO

-$135.50 M
-$50.10 M-58.67%

December 31, 2024


Summary


Performance

AVIR Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAVIRcash flowmetrics:

Quarterly CFO

-$30.40 M
-$7.36 M-31.96%

December 31, 2024


Summary


Performance

AVIR Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAVIRcash flowmetrics:

TTM CFO

-$135.50 M
-$8.56 M-6.75%

December 31, 2024


Summary


Performance

AVIR TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAVIRcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

AVIR Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-58.7%-39.2%-58.7%
3 y3 years-55.7%-72.8%-59.2%
5 y5 years-956.2%-72.8%-59.2%

AVIR Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-58.7%at low-88.6%+59.7%-59.2%+22.5%
5 y5-year-145.7%at low-109.5%+59.7%-144.2%+22.5%
alltimeall time-145.7%at low-109.5%+59.7%-144.2%+22.5%

Atea Pharmaceuticals Cash From Operations History

DateAnnualQuarterlyTTM
Dec 2024
-$135.50 M(+58.7%)
-$30.40 M(+32.0%)
-$135.50 M(+6.7%)
Sep 2024
-
-$23.04 M(-45.4%)
-$126.94 M(+4.5%)
Jun 2024
-
-$42.20 M(+5.9%)
-$121.49 M(+27.3%)
Mar 2024
-
-$39.87 M(+82.6%)
-$95.41 M(+11.7%)
Dec 2023
-$85.39 M(-29.4%)
-$21.83 M(+24.1%)
-$85.39 M(+0.3%)
Sep 2023
-
-$17.59 M(+9.1%)
-$85.11 M(-4.1%)
Jun 2023
-
-$16.12 M(-46.0%)
-$88.76 M(-3.3%)
Mar 2023
-
-$29.85 M(+38.5%)
-$91.82 M(-24.1%)
Dec 2022
-$120.98 M
-$21.55 M(+1.4%)
-$120.98 M(-30.8%)
Sep 2022
-
-$21.24 M(+10.7%)
-$174.86 M(+33.5%)
Jun 2022
-
-$19.19 M(-67.5%)
-$131.01 M(+1.4%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$59.01 M(-21.8%)
-$129.18 M(+48.5%)
Dec 2021
-$87.00 M(-129.3%)
-$75.42 M(-433.7%)
-$87.00 M(-128.3%)
Sep 2021
-
$22.60 M(-230.3%)
$306.94 M(+11.7%)
Jun 2021
-
-$17.35 M(+3.0%)
$274.86 M(-3.4%)
Mar 2021
-
-$16.84 M(-105.3%)
$284.40 M(-4.2%)
Dec 2020
$296.73 M(-2413.0%)
$318.52 M(-3459.6%)
$296.73 M(-1462.0%)
Sep 2020
-
-$9.48 M(+21.6%)
-$21.79 M(+77.0%)
Jun 2020
-
-$7.80 M(+73.0%)
-$12.31 M(+173.0%)
Mar 2020
-
-$4.51 M
-$4.51 M
Dec 2019
-$12.83 M(+62.2%)
-
-
Dec 2018
-$7.91 M
-
-

FAQ

  • What is Atea Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for Atea Pharmaceuticals?
  • What is Atea Pharmaceuticals annual CFO year-on-year change?
  • What is Atea Pharmaceuticals quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Atea Pharmaceuticals?
  • What is Atea Pharmaceuticals quarterly CFO year-on-year change?
  • What is Atea Pharmaceuticals TTM cash flow from operations?
  • What is the all time high TTM CFO for Atea Pharmaceuticals?
  • What is Atea Pharmaceuticals TTM CFO year-on-year change?

What is Atea Pharmaceuticals annual cash flow from operations?

The current annual CFO of AVIR is -$135.50 M

What is the all time high annual CFO for Atea Pharmaceuticals?

Atea Pharmaceuticals all-time high annual cash flow from operations is $296.73 M

What is Atea Pharmaceuticals annual CFO year-on-year change?

Over the past year, AVIR annual cash flow from operations has changed by -$50.10 M (-58.67%)

What is Atea Pharmaceuticals quarterly cash flow from operations?

The current quarterly CFO of AVIR is -$30.40 M

What is the all time high quarterly CFO for Atea Pharmaceuticals?

Atea Pharmaceuticals all-time high quarterly cash flow from operations is $318.52 M

What is Atea Pharmaceuticals quarterly CFO year-on-year change?

Over the past year, AVIR quarterly cash flow from operations has changed by -$8.56 M (-39.22%)

What is Atea Pharmaceuticals TTM cash flow from operations?

The current TTM CFO of AVIR is -$135.50 M

What is the all time high TTM CFO for Atea Pharmaceuticals?

Atea Pharmaceuticals all-time high TTM cash flow from operations is $306.94 M

What is Atea Pharmaceuticals TTM CFO year-on-year change?

Over the past year, AVIR TTM cash flow from operations has changed by -$50.10 M (-58.67%)